当前位置:首页 - 行情中心 - 复星医药(600196) - 财务分析

复星医药

(600196)

  

流通市值:524.75亿  总市值:661.47亿
流通股本:21.18亿   总股本:26.70亿

复星医药(600196)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润10.80亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益6366934.91万元,未分配利润2992916.51万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产12296638.83万元,负债5929703.92万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入10,073,223,477.0341,661,612,748.1529,393,385,360.9119,514,431,849.59
营业总成本9,532,295,160.540,087,325,053.4928,415,595,587.618,904,362,502.04
其他经营收益
营业利润1,375,376,200.035,228,351,339.593,906,765,379.572,761,208,390.86
利润总额1,357,544,436.175,111,983,263.873,837,343,481.792,718,481,583.08
净利润1,079,627,854.144,247,929,628.383,056,091,951.682,100,210,564.8
每股收益
其他综合收益-616,755,016.63-675,759,872.93-385,229,723.22-32,659,264.99
综合收益总额462,872,837.513,572,169,755.452,670,862,228.462,067,551,299.81
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计33,964,684,348.7333,820,671,330.2732,145,481,005.8834,342,267,603.19
非流动资产:
非流动资产合计89,001,703,917.3786,233,297,595.7885,975,257,507.1384,485,669,451.91
资产总计122,966,388,266.1120,053,968,926.05118,120,738,513.01118,827,937,055.1
流动负债:
流动负债合计36,580,714,242.4236,424,316,078.8435,086,945,012.2236,023,336,557.97
非流动负债:
非流动负债合计22,716,324,968.3621,789,302,995.8722,222,193,608.3222,489,492,119.03
负债合计59,297,039,210.7858,213,619,074.7157,309,138,620.5458,512,828,677
所有者权益(或股东权益):
归属于母公司股东权益合计49,146,744,750.4648,741,507,004.748,028,502,901.0547,397,623,662.67
股东权益合计63,669,349,055.3261,840,349,851.3460,811,599,892.4760,315,108,378.1
负债和股东权益合计122,966,388,266.1120,053,968,926.05118,120,738,513.01118,827,937,055.1
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计11,104,892,656.8943,315,418,661.3432,212,081,100.7421,388,993,511.96
经营活动现金流出小计9,956,294,869.0738,102,191,782.9928,830,312,535.0319,254,993,017.65
经营活动产生的现金流量净额1,148,597,787.825,213,226,878.353,381,768,565.712,134,000,494.31
投资活动产生的现金流量:
投资活动现金流入小计590,290,272.153,722,258,666.042,888,011,838.782,012,663,450.93
投资活动现金流出小计2,319,574,775.555,868,024,954.774,399,844,279.572,872,400,465.89
投资活动产生的现金流量净额-1,729,284,503.4-2,145,766,288.73-1,511,832,440.79-859,737,014.96
筹资活动产生的现金流量:
筹资活动现金流入小计7,953,358,102.4737,334,019,380.1526,869,314,775.6616,848,567,870.25
筹资活动现金流出小计6,675,162,903.9540,578,108,887.330,113,741,396.8518,308,768,144.07
筹资活动产生的现金流量净额1,278,195,198.52-3,244,089,507.15-3,244,426,621.19-1,460,200,273.82
汇率变动对现金及现金等价物的影响-158,570,564.25-176,810,748.88-80,826,833.379,762,529.4
现金及现金等价物净增加额538,937,918.69-353,439,666.41-1,455,317,329.64-176,174,265.07
期末现金及现金等价物余额9,576,948,039.399,038,010,120.77,936,132,457.479,215,275,522.04
补充资料:
现金及现金等价物的净增加额--353,439,666.41--176,174,265.07
最新报告期:2026-04-29
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中国银河程培,宋丽莹1.491.781.862026-04-29
中信证券陈竹,李安飞,郑浩洋1.481.791.982026-04-08
中国银河程培,宋丽莹1.491.781.862026-03-25
TOP↑